Yen-Ting Lin - Search Results

Year	Number of Results
2006	1
2009	4
2010	4
2011	2
2012	5
2013	6
2014	14
2015	14
2016	21
2017	18
2018	10
2019	16
2020	20
2021	14
2022	21
2023	22
2024	12

1

LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis.

Chen YL, Liu YN, Lin YT, Tsai MF, Wu SG, Chang TH, Hsu CL, Wu HD, Shih JY. Chen YL, et al. Among authors: lin yt. J Biomed Sci. 2023 Sep 19;30(1):80. doi: 10.1186/s12929-023-00973-9. J Biomed Sci. 2023. PMID: 37726723 Free PMC article.

2

Advances in Antibody-Based Therapeutics for Cerebral Ischemia.

Sun JM, Yen TL, Jan JS, Mwale PF, Teng RD, Taliyan R, Hsieh CT, Yang CH. Sun JM, et al. Among authors: yen tl. Pharmaceutics. 2022 Dec 31;15(1):145. doi: 10.3390/pharmaceutics15010145. Pharmaceutics. 2022. PMID: 36678774 Free PMC article. Review.

3

Stage Shift Improves Lung Cancer Survival: Real-World Evidence.

Yang CY, Lin YT, Lin LJ, Chang YH, Chen HY, Wang YP, Shih JY, Yu CJ, Yang PC. Yang CY, et al. Among authors: lin yt. J Thorac Oncol. 2023 Jan;18(1):47-56. doi: 10.1016/j.jtho.2022.09.005. Epub 2022 Sep 19. J Thorac Oncol. 2023. PMID: 37650698 Free article.

4

Garcinol acts as a novel integrin α_IIbβ₃ inhibitor in human platelets.

Hsia CW, Huang WC, Jayakumar T, Hsia CH, Hou SM, Chang CC, Yen TL, Sheu JR. Hsia CW, et al. Among authors: yen tl. Life Sci. 2023 Aug 1;326:121791. doi: 10.1016/j.lfs.2023.121791. Epub 2023 May 19. Life Sci. 2023. PMID: 37211346

5

The pharmacodynamics of antiplatelet compounds in thrombosis treatment.

Jayakumar T, Yang CH, Geraldine P, Yen TL, Sheu JR. Jayakumar T, et al. Among authors: yen tl. Expert Opin Drug Metab Toxicol. 2016 Jun;12(6):615-32. doi: 10.1080/17425255.2016.1176141. Epub 2016 Apr 26. Expert Opin Drug Metab Toxicol. 2016. PMID: 27055051 Review.

6

Not All EGFR Exon 20 Insertions Are Created Equal.

Lin YT, Shih JY. Lin YT, et al. JTO Clin Res Rep. 2020 Sep 14;1(3):100069. doi: 10.1016/j.jtocrr.2020.100069. eCollection 2020 Sep. JTO Clin Res Rep. 2020. PMID: 34589951 Free PMC article. No abstract available.

7

Chinese medicines and bioactive compounds for treatment of stroke.

Jayakumar T, Elizebeth AR, Yen TL, Sheu JR. Jayakumar T, et al. Among authors: yen tl. Chin J Integr Med. 2015 Feb;21(2):90-101. doi: 10.1007/s11655-014-1782-2. Epub 2014 Jul 10. Chin J Integr Med. 2015. PMID: 25012632 Review.

8

Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB.

Satapathy MK, Yen TL, Jan JS, Tang RD, Wang JY, Taliyan R, Yang CH. Satapathy MK, et al. Among authors: yen tl. Pharmaceutics. 2021 Jul 31;13(8):1183. doi: 10.3390/pharmaceutics13081183. Pharmaceutics. 2021. PMID: 34452143 Free PMC article. Review.

9

Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Inhibitors in NSCLC: Two Heads Are Better Than One.

Lin YT, Shih JY. Lin YT, et al. J Thorac Oncol. 2022 Feb;17(2):176-178. doi: 10.1016/j.jtho.2021.11.004. J Thorac Oncol. 2022. PMID: 35074222 Free article. No abstract available.

10

Multi-Targeting Andrographolide, a Novel NF-κB Inhibitor, as a Potential Therapeutic Agent for Stroke.

Yang CH, Yen TL, Hsu CY, Thomas PA, Sheu JR, Jayakumar T. Yang CH, et al. Among authors: yen tl. Int J Mol Sci. 2017 Jul 27;18(8):1638. doi: 10.3390/ijms18081638. Int J Mol Sci. 2017. PMID: 28749412 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

182 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Results by year